Ancora Heart

Ancora Heart, Inc. is a privately held medical device company headquartered at 4001 Burton Drive, Santa Clara, California, developing transcatheter therapies for people living with heart failure. Its lead product is the AccuCinch Ventricular Restoration System, a completely transcatheter implant designed to reduce the size of an enlarged left ventricle and restore cardiac structure and function in patients with heart failure with reduced ejection fraction (HFrEF) who remain symptomatic on guideline-directed medical therapy. The device is investigational and is being evaluated in the CORCINCH-HF study (NCT04331769), a prospective randomized international trial enrolling up to 400 patients across as many as 80 centers, alongside the CORCINCH-EU program in Europe. Ancora Heart is a medical device manufacturer rather than a software company: it publishes a marketing and clinical-information website for patients and physicians, and operates no public developer program, API, or SDK.

Ancora Heart is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Health Care, Cardiology, and Heart Failure.

Ancora Heart’s developer surface includes support, engineering blog, YouTube channel, and 9 more developer resources.

🌐 Visit website 📡 Source on GitHub

11.6/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0

0 APIs

CompanyMedical DevicesHealth CareCardiologyHeart FailureClinical TrialsTranscatheter TherapyMedical Technology

Kin Score

Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0

Composite quality — 11.6/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 1.1 / 17

Commercial Clarity 3.6 / 17

Operational Transparency 0.0 / 11

Governance 0.0 / 10

Discoverability 4.3 / 9

Regulatory Posture 2.6 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/ancora-heart: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Learn 1

Tutorials, courses, talks, and written guidance

YouTube

YouTube

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 2

Pricing, plans, and the legal terms of use

TermsOfService

TermsOfService

PrivacyPolicy

PrivacyPolicy

Company 7

The organization behind the API

Website

About

Blog

BlogRSS

LinkedIn

Twitter

Twitter

Facebook

Facebook

Scroll for all 7

Source (apis.yml)

aid: ancora-heart
name: Ancora Heart
description: 'Ancora Heart, Inc. is a privately held medical device company headquartered at 4001 Burton Drive, Santa Clara,
  California, developing transcatheter therapies for people living with heart failure. Its lead product is the AccuCinch Ventricular
  Restoration System, a completely transcatheter implant designed to reduce the size of an enlarged left ventricle and restore
  cardiac structure and function in patients with heart failure with reduced ejection fraction (HFrEF) who remain symptomatic
  on guideline-directed medical therapy. The device is investigational and is being evaluated in the CORCINCH-HF study (NCT04331769),
  a prospective randomized international trial enrolling up to 400 patients across as many as 80 centers, alongside the CORCINCH-EU
  program in Europe. Ancora Heart is a medical device manufacturer rather than a software company: it publishes a marketing
  and clinical-information website for patients and physicians, and operates no public developer program, API, or SDK.'
url: https://raw.githubusercontent.com/api-evangelist/ancora-heart/refs/heads/main/apis.yml
image: https://www.ancoraheart.com/wp-content/themes/ancora/public/images/NEW_AncoraLogo_Color.svg
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-06'
modified: '2026-08-06'
tags:
- Company
- Medical Devices
- Health Care
- Cardiology
- Heart Failure
- Clinical Trials
- Transcatheter Therapy
- Medical Technology
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/ancora-heart-domain-security.yml
- type: Website
  url: https://www.ancoraheart.com/
- type: About
  url: https://www.ancoraheart.com/about-us/
- type: Support
  url: https://www.ancoraheart.com/contact/
- type: Blog
  url: https://www.ancoraheart.com/in-the-news/
- type: BlogRSS
  url: https://www.ancoraheart.com/feed/
- type: TermsOfService
  url: https://www.ancoraheart.com/terms-of-use/
- type: PrivacyPolicy
  url: https://www.ancoraheart.com/privacy-policy/
- type: LinkedIn
  url: https://www.linkedin.com/company/24214239/
- type: Twitter
  url: https://twitter.com/AncoraHeart
- type: YouTube
  url: https://www.youtube.com/channel/UCufcpLIcuygJzvUs1tlHwUA
- type: Facebook
  url: https://www.facebook.com/AncoraHeart
x-enrichment:
  date: '2026-08-06'
  status: minimal
  artifacts_added: 1
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Ancora Heart manufactures an implantable cardiac device (the AccuCinch Ventricular Restoration System) and runs
    ancoraheart.com purely as a WordPress marketing and clinical-trial information site; the only machine-readable endpoint
    on the domain is the WordPress core REST API that ships with the CMS, and every contract-discovery path returns the site's
    soft-404 HTML shell with a 200.
  evidence:
  - url: https://www.ancoraheart.com/openapi.json
    status: 200
  - url: https://www.ancoraheart.com/this-path-definitely-does-not-exist-9x8z7
    status: 200
  - url: https://www.ancoraheart.com/.well-known/agent-card.json
    status: 200
  - url: https://www.ancoraheart.com/.well-known/security.txt
    status: 404
  - url: https://www.ancoraheart.com/llms.txt
    status: 404
  - url: https://www.ancoraheart.com/wp-json/
    status: 200
  checked: '2026-08-06'